SOLIGENIX, INC.
Pharmaceutical Preparations · PRINCETON · NJ
Moderate confidence (50%)
Updated Oct 15, 2026, 12:03 AM
What is happening
Derived by rule set status-rules-2026.09.7
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
Latest material event: SOLIGENIX, INC. received a delisting notice from its exchange (Jun 10, 2026)
Timeline
Every material event, newest first. History is never overwritten.
SOLIGENIX, INC. received a delisting notice from its exchange
Jun 10, 2026
Delisting notice received
- SEC EDGAR — “Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On June 10, 2026, Soligenix, Inc. (the Company ) received a written notice (the Bid Price Notice ) from the Listing Qualifications department (the Nasdaq Staff ) of The Nasdaq Stock Market ( Nasdaq ) indicating that the Company is not in compliance with the $1.00 minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on the Nasdaq Capital Market. The notification of noncompliance has no immediate effect on the listing or trading of the Company…”
Company information
- Founded
- —
- Employees (estimate)
- —
- Industry
- Pharmaceutical Preparations
- Subindustry
- —
- Listing
- SEC lists the ticker SNGX on Nasdaq.
- SEC CIK
- 0000812796
- Website
- —
- —
- Headquarters
- PRINCETON, NJ
- Also known as
- DOR BIOPHARMA INC, ENDOREX CORP, IMMUNOTHERAPEUTICS INC, SOLIGENIX, INC.
- Legal entities
- SOLIGENIX, INC.
Sources
Every material source used to build this profile.
SEC Company Submissions (TIER 1 · UNVERIFIED)
SOLIGENIX, INC. — Pharmaceutical Preparations (SIC 2834) — PRINCETON, NJ
View source recordSEC EDGAR (TIER 1 · UNVERIFIED)
Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On June 10, 2026, Soligenix, Inc. (the Company ) received a written notice (the Bid Price Notice ) from the Listing Qualifications department (the Nasdaq Staff ) of The Nasdaq Stock Market ( Nasdaq ) indicating that the Company is not in compliance with the $1.00 minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on the Nasdaq Capital Market. The notification of noncompliance has no immediate effect on the listing or trading of the Company…
View source record
Status history
Every derived status, with the rule that produced it.
- DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:32 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:12 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 15, 2026, 12:32 PM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 14, 2026, 04:45 PM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- UNKNOWN → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 8, 2026, 03:12 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.